PML is a tumor suppressor implicated in leukemia and cancer pathogenesis. PML epitomizes a multiprotein nuclear structure, the PML-nuclear body (PML-NB), whose proper formation and function depends on PML. Studies in knockout (KO) mice and cells unraveled an essential pleiotropic role for PML in multiple p53-dependent and -independent apoptotic pathways. As a result, Pml À/À mice and cells are protected from apoptosis triggered by a number of stimuli such as ionizing radiation, interferon, ceramide, Fas and TNF. It is becoming apparent that PML and the PML-NB act as molecular hubs for the induction and/or reinforcement of programmed cell death through a selective and dynamic regulation of proapoptotic transcriptional events. In addition, recent observations propose a role for PML in checkpoint responses upon DNA damage. Moreover, PML and the PML-NB have also been implicated in the control of genomic stability and DNA repair. Here, we will discuss the molecular mechanisms by which PML regulates these processes and the implication of these findings for cancer pathogenesis and therapy.
Introduction
The PML tumor suppressor gene, also known as myl, was originally identified cloning the (15;17) chromosomal translocation specific of acute promyelocytic leukemia (APL), a distinct subtype of acute myeloid leukemia (AML). As a consequence of this translocation, PML fuses to the retinoic acid (RA) receptor alpha (RARa) gene. Two fusion genes are generated encoding PML-RARa and RARa-PML fusion proteins, which coexist in the leukemic cells (for a review, see Melnick and Licht, 1999) . The PML-RARa oncoprotein was found to inhibit RARa transcriptional function, and also to associate physically with PML, thus potentially interfering with its function (reviewed in Piazza et al., 2001) . PML has therefore become the object of intense research on the basis of this premise. This hypothesis was further corroborated by the discovery that while PML is typically concentrated in subnuclear structures variably named PML-nuclear bodies (PML-NBs), Kremer bodies, nuclear domain 10 (ND10) or PML oncogenic domains (POD) (Jensen et al., 2001 and references cited therein), in the APL blasts, PML-RARa physically associates with PML and causes its delocalization into microspeckled nuclear structures with consequent disruption of the PML-NB (Melnich and Licht, 1999) . Furthermore, in vivo, PML-RARa causes leukemia with APL features when expressed in the promyelocytic/myeloid compartment of transgenic mice, while dominant-negative RARa mutants that do not interfere with PML function fail to do so, underscoring the importance in leukemogenesis of the functional disruption of PML and the PML-NB (Pandolfi, 2001 and references therein).
PML is one of the founding members of a large family of proteins harboring a distinctive zinc finger domain termed RING (really interesting gene), some of which have also been implicated in tumor suppression and the control of genomic stability (e.g. BRCA1; Zhong et al., 2000b; Jensen et al., 2001 ; and references cited therein). The PML RING finger is located N-terminally and is followed by two additional zinc fingers (B-boxes) and an a-helical coiled-coil motif (collectively referred to as the RBCC domain). The RBCC domain mediates proteinprotein interactions and is responsible for PML multimerization, localization in the PML-NB and heterodimerization with PML-RARa, but does not confer DNA-binding capability to PML (Zhong et al., 2000b; Jensen et al., 2001) .
Multiple PML isoforms have been identified due to alternative splicing of the carboxyl (C)-terminal exons (Jensen et al., 2001) . In addition, distinct PML Ctermini identify subgroups of PML isoforms generated by alternative usage of exons located in the middle of the gene (e.g. exon 5; Pandolfi et al., 1992; Jensen et al., 2001) . The biological relevance of the various PML isoforms has been recently underscored by the recognition that PML C-termini dictate PML protein-protein interaction specificity. For instance, only one PML C-terminus mediates PML/p53 physical association (PML IV according to Fogal et al., 2000; Guo et al., 2000; Jensen et al., 2001) . Furthermore, while PML is mostly associated with the NB and the nuclear matrix some of these isoforms are found to accumulate into the cytosolic fraction (Jensen et al., 2001 and references therein), therefore suggesting that PML might have additional as yet unidentified functions independent from the PML-NB.
A number of reports identified PML as a potent growth suppressor when overexpressed in various cancer cell lines, either through the induction of cell cycle arrest or apoptosis (Salomoni and Pandolfi, 2000 and references therein) . However, the role of PML in tumorigenesis and leukemogenesis has been firmly established only by in vivo analysis of transgenic and knockout (KO) mice: firstly, the progressive reduction of Pml gene dosage obtained by crossing PML-RARa transgenic mice with Pml À/À mice resulted in a dramatic increase in the incidence of leukemia and in an acceleration of leukemia onset (Rego et al., 2001) . Secondly, Pml À/À mice are highly susceptible to develop tumors in in vivo models of chemical-induced carcinogenesis (Wang et al., 1998a) . Analysis of Pml À/À mice also demonstrated that PML exerts its tumor suppressive role at least in part by coordinating a number of proapoptotic responses of critical relevance both in the maintenance of cellular homeostasis in several organs including the bone marrow, as well as in the clearance of cells in response to stress/DNA damage (Wang et al., 1998b) . Here, we will review and discuss the known molecular mechanisms by which PML and the PML-NB control programmed cell death.
Role of PML in multiple apoptotic pathways
PML is ubiquitously expressed, albeit at very low levels and PML-NBs are detected in almost any cell of the developing embryo or the adult organism. Nonetheless, PML is markedly upregulated upon a number of cellular stresses including inflammation, oncogenic transformation and proapoptotic stimuli such as for instance ionizing radiation (Terris et al., 1995; Ferbeyre et al., 2000; Pearson et al., 2000; Carbone et al., 2002) . Under these conditions, the number and the size of the PMLNBs (and hence the matrix-associated PML fraction), as well as the soluble nonmatrix PML nuclear and cytosolic fractions increase (Salomoni, Bernardi and Pandolfi, unpublished observation) . These stimuli also trigger a dynamic reorganization of the PML-NB with transient recruitment and release of proteins from these nuclear organelles, as we will thoroughly discuss throughout the following paragraphs. The PML-NB can be therefore regarded as a multiprotein stress response machinery.
p53-dependent and -independent apoptosis
Definitive proof of the importance of PML in modulating programmed cell death programs comes from studies conducted in Pml À/À mice and cells. Pml À/À mice are resistant to the lethal effects of both g-irradiation and CD95/Fas (Wang et al., 1998b) , while primary Pml À/À splenocytes, thymocytes mouse embryonic fibroblasts (MEFs) and hematopoietic cells are resistant to apoptosis induced by either CD95/Fas or g-irradiation, as well as by ceramide, TNF and IFN (Wang et al., 1998b; Wu et al., 2003) . Caspase activation upon these stimuli is invariably impaired in Pml À/À cells (Wang et al., 1998b; Wu et al., 2003) . PML is therefore essential for both p53-dependent (e.g. apoptosis of primary thymocytes upon g-rays: Wang et al., 1998b) as well as p53-independent apoptotic programs (e.g. apoptosis of activated splenocytes or hepatocytes upon CD95/Fas; Wang et al., 1998b; Zhong et al., 2000c) (Figure 1 ).
In addition, hemopoietic progenitors from PML-RARa transgenic mice, in which the expression of the transgene is restricted to the myeloid promyelocytic compartment (He et al., 1997) , are resistant to the very same apoptotic stimuli that depend on PML to be properly executed in agreement with the dominant-negative action exerted by PML-RARa on PML function (Wang et al., 1998b) . Furthermore, protection from apoptosis by PML-RARa is even more pronounced in compound mutants in which PML hemizygosity is obtained by crossing PMLRARa transgenic mice with Pml À/À mice (Rego et al., 2001 ). These data demonstrate that PML-RARa can indeed interfere with PML function in vivo. Based on these observations, the inactivation of PML proapoptotic activity by the fusion protein could be a crucial step in APL leukemogenesis and/or in determining response to proapoptotic chemotherapeutic agents (see the following paragraphs).
Caspase-dependent and -independent cell death
Although PML is essential for a number of caspasedependent apoptotic stimuli, it has also been reported À/À mice and cells were subjected to various apoptogenic stimuli and their response was compared to the response observed in wild-type cells. This analysis allowed concluding that PML is essential to the completion of apoptotic programs induced by different stimuli. (b) PML is critical for both p53-dependent and -independent apoptosis. In transgenic mice, the PML-RARa fusion protein exerts a dominant-negative effect on PML by inhibiting apoptosis induced by the same stimuli that forced overexpression of PML can lead to rapid cell death in the absence of the typical features of apoptosis, such as DNA condensation. The overexpression of PML does not lead to induction of caspase-3 activity, implying that PML may trigger cell death in a caspase-independent manner (Quignon et al., 1998) . However, a comprehensive assessment of activation of caspases other than caspase-3 is needed to exclude their involvement in PML-induced cell death. In support of the activation of caspase-independent mechanisms for cell death upon PML overexpression, broad-spectrum caspase inhibitors such as z-VAD-fmk enhanced rather than blocked cell death (Quignon et al., 1998) . Serum deprivation, staurosporine, overexpression of oncogenes such as c-MYC or E1A, DNA damage and IL-3 withdrawal can also trigger cell death through caspaseindependent mechanisms. Although the involvement of PML in the induction of both caspase-dependent andindependent apoptosis is seemingly contradictory, it could be proposed that while PML would be essential for the proper function of proapoptotic transcription factors (see the next paragraph), ultimately leading to caspase activation, higher levels of PML expression might trigger cell death independent of transcription or caspase activation through other mechanisms yet to be uncovered (e.g. protein sequestration/titration into the PML-NB). The physiological significance of these findings remains to be determined, as it is not known whether the levels of PML reached in overexpression experiments are ever observed in physiological conditions. Furthermore, these observations would need to be corroborated by firm mechanistic insights, which are still missing at present.
PML and PML-NBs: hubs of a proapoptotic transcriptional network
Overwhelming evidence obtained in Pml null primary cells of various histological origins has recently established a key role for PML and the PML-NB in the regulation and functional activation of a number of proapoptotic/tumor suppressive transcription factors. These transcription factors are known to be essential for the induction of apoptosis in response to the same various stimuli that depend on PML to be properly executed (for the transcriptional role of PML and the PML-NB, see also Zhong et al., 2000a and references therein) . These findings on the one hand, point to the PML-NBs as general sites of transcriptional regulation, on the other explain how PML could coordinate both p53-dependent and -independent apoptotic responses.
PML and p53
Pml À/À mice are resistant to the lethal effects of g-radiation, thus demonstrating that PML is involved in modulating the apoptotic response to DNA damage. The tumor suppressor p53 plays a key role in this process. In particular, p53 À/À thymocytes are completely resistant to g-radiation-induced apoptosis, indicating that normal p53 function is absolutely required for DNA damage-induced apoptosis in this cell type. Pml À/À thymocytes are also resistant to g-radiation-induced apoptosis, although to a lesser extent than p53
thymocytes, suggesting that Pml may be important in mediating proper p53 proapoptotic functions in vivo (Guo et al., 2000) . In support of this notion, protection from apoptosis in Pml À/À thymocytes correlates with impaired induction of bona fide p53 target genes, such as the proapoptotic gene bax and the inhibitor of cell cycle p21 (Guo et al., 2000) . Indeed, PML directly interacts with the DNA-binding domain of p53, colocalizes with p53 in the PML-NB and acts as a p53 transcriptional coactivator (Fogal et al., 2000; Guo et al., 2000; Pearson et al., 2000) . PML specifically interacts with p53 through the C-terminal domain of one of the NB-specific isoforms of PML (PML IV; Fogal et al., 2000; Guo et al., 2000) . Thus, the p53/PML functional interaction is isoform specific, although the ability of the various PML isoforms to homodimerize/oligomerize through the RBCC motif may in principle allow different isoforms to still potentiate p53 activity through indirect interaction. Upon g-irradiation, p53 is activated by several mechanisms, one of which is acetylation. Acetylation of p53 enhances its ability to bind DNA and activate transcription. In Pml À/À cells, the gradiation-induced acetylation of p53 is impaired, indicating that PML might regulate p53 transcriptional function favoring its acetylation (Guo et al., 2000) . PML has also been shown to regulate p53 activity by promoting its acetylation when premature cellular senescence is triggered by oncogenic Ras Val12 overexpression (Pearson et al., 2000) . Although PML does not possess intrinsic acetyltransferase activity, it directly interacts with the acetyltransferase CBP and colocalizes with CBP/p300 and p53 in the PML-NB (Guo et al., 2000; Pearson et al., 2000 and references therein) ( Figure 2) . Strikingly, the ability of PML to activate p53 transcription is PML-NB dependent, since a mutant of PML that does not localize in the PML-NB, but still interacts with p53 and CBP, is unable to coactivate p53 transcription (Guo et al., 2000) . Thus, PML modulates p53 function at least in part through the PML-NB, in turn potentiating its proapoptotic activity.
The ability of PML and the PML-NB to potentiate p53 function goes beyond the sole regulation of p53 acetylation. Recent reports identified in the PML-NB two additional important p53 regulators: HIPK2 a p53 kinase and HAUSP, a p53 deubiquitilase. The homeodomain-interacting protein kinase-2 (HIPK2) directly interacts with and phosphorylates p53 at serine 46, resulting in the activation of p53 proapoptotic transcription (D'Orazi et al., 2002; Hofmann et al., 2002) . p53 is a short-lived protein that is maintained at low levels in normal cells by Mdm2-mediated ubiquitination and subsequent proteolysis. Stabilization of the p53 protein is therefore crucial in tumor suppression. The Herpesvirus-associated ubiquitin-specific protease (HAUSP) interacts with and strongly stabilizes p53 even in the presence of excess Mdm2 and induces p53-dependent apoptosis . HAUSP has an intrinsic enzymatic activity that specifically deubiquitinates p53 both in vitro and in vivo, therefore inducing p53 stabilization and activation. Thus, acetylation, phosphorylation and deubiquitination of p53 could occur in the PML-NB. It remains to be addressed whether in Pml À/À cells, as a consequence of the disruption of the PML-NB (see the following paragraphs), phosphorylation and deubiquitination of p53 are also impaired. Nevertheless, these findings strongly suggest that the PML-NB could act as mini-factories for p53 post-translational modification to which p53 is transiently recruited upon DNA damage and other forms of stress.
Daxx and PML
PML is necessary for FAS-and TNF-induced apoptosis, thus indicating that PML can also modulate p53-independent proapoptotic pathways. However, unlike p53-dependent apoptosis, which is triggered from the nucleus, FAS/TNF apoptotic signals are initiated by the death-inducing signaling complex (DISC) at the plasma membrane and are then transduced to a caspase proteolytic cascade. Thus, the proapoptotic signal would need to be transduced from the plasma membrane to the PML-NB. One of the most relevant candidates to serve this bridging function between the DISC and the PML-NB is DAXX, originally cloned as a FAS-interacting protein and found to act as a positive mediator of FAS-and TGFb-induced apoptosis (Perlman et al., 2001 and references cited therein). DAXX directly interacts both with PML in the PML-NB as well as PML-RARa (Torii et al., 1999; Zhong et al., 2000b) . PML and DAXX cooperate in potentiating FASinduced apoptosis (Torii et al., 1999) . In the absence of Pml, DAXX is delocalized from the PML-NB and accumulates in chromatin-dense nuclear regions (Zhong et al., 2000b) . Furthermore, in Pml À/À cells the ability of DAXX to trigger apoptosis and to potentiate the FAS proapoptotic signal is markedly impaired (Zhong et al., 2000b) . DAXX is a transcriptional repressor and its sequestration in the PML-NB has been shown to block this activity. Conversely, the expression of PML-RARa results in the delocalization of DAXX from the PML-NB, in turn enhancing DAXX transcriptional repression (Li et al., 2000) . Recently, it has been shown that DAXX movement from the PML-NB can be regulated by the homeodomain-interacting protein kinase-1 (HIPK1) through physical association. However, subsequent phosphorylation of Daxx on Ser 669 by this kinase attenuates DAXX transcriptional repression (Ecsedy et al., 2003) . Taken together, all these observations may suggest a model by which DAXX represses antiapoptotic genes and PML would antagonize this activity through titration of DAXX in the NBs leading to potentiation of apoptosis (Figure 3a) . However, this would not explain why DAXX would need to move/accumulate in the nucleus and the PML-NB just to be repressed. Furthermore, the transcriptional data by which PML antagonizes DAXX have been obtained utilizing a GAL4-DAXX overexpressed condition and have not been validated in Pml À/À cells with wild-type DAXX on its own physiological target genes. In a more plausible working hypothesis, a DAXX/PML complex released from the PML-NB would have a distinct transcriptional function and a direct proapoptotic activity (Figure 3b ). Since DISC-induced apoptosis depends on caspase activation, in such transcriptional models, protection from FAS/TNF observed in Pml null cells/mice might be due to the fact that factors normally required for the proper execution (e.g. caspases themselves) or the regulation of the caspase proteolytic cascade are misexpresssed in the absence of PML. To this end, the identification of DAXX/PML target genes in response to these stimuli by high-throughput analysis is of critical importance. The picture is further complicated by the fact that although DAXX can exert proapoptotic functions, its targeted disruption results in embryonic lethality due to increased apoptosis, suggesting a more complex role for DAXX during embryonic development (Michaelson et al., 1999) . Although the mechanisms that regulate DAXX shuttling between the cytosol and the PML-NB are poorly understood, it has been recently reported that in B-lymphocytes IFN-a, which is known to upregulate PML markedly at the transcription level (Lavau et al., 1995; Stadler et al., 1995) , can also induce DAXX and cause its nuclear translocation (Shimoda et al., 2002) . This movement depends on the activity of the tyk2 kinase as it is completely abrogated in tyk2-deficient mice (Shimoda et al., 2002) . IFN and Fas could therefore cooperate in the induction of apoptosis in the B-cell In the current model of PML modulation of p53 activity, p53 can be recruited to the PML-NB upon stimuli such as g-irradiation in primary thymocytes. The presence of the acetyl transferase CBP/ p300 in the PML-NB favors the formation of a ternary complex with consequent acetylation of p53. Acetylation results in p53 transcriptional activation of target genes. As transcription does not seem to occur in the NB, acetylated p53 has to leave the NB and move to the promoter of its target genes. One possible hypothetical mechanism by which this could be achieved is through PML desumoylation by the desumoylase SUPR-1 and its consequent mobilization compartment through facilitation of PML/DAXX functional interaction.
NF-kB/Rel and PML
As aforementioned, Pml inactivation also protects cells from TNF-induced apoptosis in the bone marrow (Wang et al., 1998b) . Conversely, it was recently shown that ectopic expression of PML sensitizes to TNFinduced apoptosis TNF-resistant cell lines such as U2OS and other cell lines (Wu et al., 2003) . Once again, at the transcription level PML was found to modulate a survival pathway negatively, which in turn antagonizes TNF proapoptotic activity. PML has been shown to act as a transcriptional repressor of NF-kB by physically interacting with RelA/p65, one of the two subunits of NF-kB, and inhibiting its DNA-binding potential. PML physically interacts with RelA/p65 in vivo and sequesters it in the PML-NB. Indeed, overexpression of NF-kB antagonizes cell death induced by PML/TNF (Wu et al., 2003) . In agreement with these findings, PML was found to repress the TNF-dependent induction of the zinc finger protein A20. A20 is an NF-kB target, inducible by TNF, and it is a potent inhibitor of TNF-induced apoptosis (Wu et al., 2002) . In summary, PML can modulate both p53-dependent and -independent pathways for apoptosis at the transcriptional level at least in part through the NB.
PML, checkpoint control and apoptosis
Since PML is implicated in the induction and potentiation of multiple apoptotic responses and, more in general, in the cellular response to DNA damage, it is conceivable that DNA damage checkpoint kinases would be found to signal to PML, either indirectly or through direct phosphorylation. Although very little is known at present, PML has already been positioned in this signaling network. Indeed, it has been known for a long time that PML is phosphorylated in vivo on both tyrosine and serine residues (Chang et al., 1995) . More recently, PML has been found to be a direct substrate of the hCds1/Chk2 checkpoint kinase (Yang et al., 2002) . hCds1/Chk2 can act as a tumor suppressor and is mutated in tumors as well as in a variant form of the cancer susceptibility syndrome Li-Fraumeni (Bell et al., 1999; Wu et al., 2001) . hCds1/Chk2 is part of the DNA damage checkpoint response: it is phosphorylated by the ATM kinase upon DNA damage and can regulate p53 and BRCA1 to induce apoptosis, cell cycle arrest and DNA repair (Matsuoka et al., 1998; Brown et al., 1999; Chehab et al., 2000; Hirao et al., 2000) . PML was found to be phosphorylated both in vitro and in vivo by hCds1/ Chk2 on serine 117, a residue shared by all the PML isoforms. PML phosphorylation increased upon girradiation and was abrogated by the mutation of Ser 117 to alanine. Moreover, hCds1/Chk2 physically interacts and colocalizes with PML in the PML-NB. Surprisingly, hCds1/Chk2 and PML no longer interact upon g-irradiation, suggesting that PML phosphorylation by hCds1/Chk2 may in turn induce its mobilization. Importantly, the ability of the PML S117A mutant to induce apoptosis with or without g-irradiation is markedly impaired (Yang et al., 2002) . The mechanism by which PML would cooperate with hCds1/Chk2 in the induction of apoptosis upon g-irradiation is still unclear. hCds1/Chk2 can directly phosphorylate p53 on Ser 20, thereby promoting its stabilization and activation. Nevertheless, PML phosphorylation by hCds1/Chk2 could potentiate the ability of PML to modulate p53 function, although no data have been reported in support of this hypothesis thus far. Alternatively, it is also possible that PML regulates hCds1/Chk2 activity on p53 as these proteins are found to accumulate in the PML-NB.
The fact that PML is a substrate of hCds1/Chk2 firmly places PML in the checkpoint response to DNA damage. It will be interesting to determine whether other checkpoint kinases could directly or indirectly signal to PML. Although phosphorylation by hCds1/Chk2 seems to be relevant for PML's ability to induce apoptosis, a more general question that would need to be addressed Figure 3 Possible models of DAXX-PML cooperation in the induction of apoptosis. DAXX is a transcriptional repressor localizing to the nuclear membrane, where it interacts with FAS, as well as in the PML-NB. DAXX acts as a positive mediator of FAS-and TGFb-induced apoptosis. A model can be proposed in which upon FAS-L (FAS ligand) binding to FAS, two apoptotic pathways are activated. In the cytoplasm, a caspase proteolytic cascade directly induces apoptosis. A reinforcement mechanism could be initiated by DAXX translocation to the nucleus, where it would be inducing apoptosis in cooperation with PML. DAXX is a transcriptional repressor and PML its thought to antagonize its transcriptional function, although these observations have been made in an overepression system. In this scenario and to reconcile all the known observations, it could be proposed that PML antagonizes DAXX-mediated transcriptional repression of antiapoptotic genes by titrating it in the PML-NB (a). PML-mediated blockade of DAXX function would result in the reinforcement of the apoptotic signal. However, according to this model it would be hard to explain why a transcription factor would be translocated to the nucleus just to be titrated and inhibited in the NB. In an alternative model, a DAXX/PML complex, which forms in the NB, could be dynamically released from the NB by the action of the PML desumoylase SUPR-1 or upon DAXX phosphorylation (b). Nuclear DAXX/PML could have novel transcriptional functions (e.g. activation of target genes) and a direct proapoptotic activity is whether phosphorylation of PML by checkpoint kinases also activates other PML-dependent functions such as its ability to arrest cell cycle or a possible role in DNA repair (see the next paragraph). It is in fact tempting to speculate that the qualitative and quantitative modulation of PML phosphorylation by checkpoint kinases could shift its function from the induction of G1-arrest and/or DNA repair to the induction of apoptosis.
A PML's role in DNA repair and genomic stability?
Recent reports have implicated PML and the PML-NB in processes of DNA recombination and repair as well as checkpoint activation. This correlation originated from the initial observation that several proteins involved in the maintenance of genomic stability and/ or DNA recombination localize in the PML-NB at specific stages of cell cycle progression or upon DNA damage.
The first evidence for a role of PML in the control of genomic stability was obtained by recognizing a functional crosstalk between the PML and BLM protein, which is mutated and defective in the Bloom Syndrome (BS). BLM is homologous to the REC-Q DNA helicase of E. coli and functions as a 3 0 -5 0 DNA helicase, playing a direct role in the maintenance of genomic stability possibly through the control of homologous recombination (Hanada et al., 1997; Harmon and Kowalczykowski, 1998) . BLM has been found to be concentrated in the PML-NB in both primary and transformed cells, where it colocalizes with PML ( Figure 4a ; Zhong et al., 1999; Yankiwski et al., 2000) . Notably, although the localization of PML was found unperturbed in cells from BS patients, BLM failed to accumulate in speckled nuclear structures in Pml null cells and is delocalized from the PML-NB in APL cells (Zhong et al., 1999) . Although the function of BLM in DNA recombination and repair is still unclear, it has been known for a long time that cells from BS patients display genomic instability in the form of a high rate of sister-chromatid exchange and chromosome breakage (SCE) (Ellis et al., 1995) . Interestingly, primary fibroblasts from Pml À/À mice also showed a higher rate of spontaneous SCE compared to wild-type cells, thus pointing at a possible role for PML in the maintenance of genomic stability either directly, or most likely in cooperation with proteins devoted to DNA repair such as BLM (Zhong et al., 1999) . BLM expression and localization are regulated during the cell cycle, with peaks of expression in S/G2 and predominant localization to the PML-NB, except during the S phase when the protein acquires nucleolar localization (Yankiwski et al., 2000) . Interestingly, BLM and PML were shown to colocalize in the PML-NB mainly in late S/G2 when the recombination/repair proteins RAD51 and replication factor (RP)-A were also found with BLM in a fraction of the PML-NB (Figure 4a ; Bischof et al., 2001) . PML, BLM, RAD51 and RP-A colocalization in the PML-NB became even more evident after girradiation of normal human fibroblasts (Bischof et al., 2001) . Once again, colocalization was found to occur as the cells arrested in G2 (Bischof et al., 2001) . The PML and BLM foci were also found to coincide with sites of DNA repair in human fibroblasts after g-irradiation Figure 4 DNA recombination and/or repair factors colocalize with PML in the PML-NB. Different reports have implicated PML in the processes of DNA recombination and DNA repair; however, this correlation is still based mainly on colocalization data. The arrangement of the various proteins in these complexes as depicted in the cartoon is therefore purely hypothetical, as no direct interaction of PML with these factors has been formally proven so far. (a) In untreated and unsynchronized cells, the BLM protein partially colocalizes with PML in the PML-NB, together with the DNA recombination and replication proteins RAD51 and RP-A. The extent of BLM-PML-RAD51-RP-A colocalization increase as cells progress to the late S/G2 phase of the cell cycle, when homologous recombination occurs. The Mre11-RAD50-NBS1 complex was also found to partially colocalize with PML in the PML-NB preferentially in G1 (Mirzoeva and Petrini, 2003) ; however, it is not known whether this interaction still occurs in G2. (b) Upon g-irradiation, human fibroblasts repair their DNA at early time points. Whether PML colocalizes with BLM at this stage is not known; however, at later time points after g-irradiation, when the cells are arrested in G2, PML colocalizationwith BLM-RAD51-RP-A increases with respect to untreated cells. Conversely, the colocalization of PML with the Mre11-RAD50-NBS1 complex is lost at early time points after g-irradiation and is resumed at late time points. (c) In ALT cells, PML colocalizes with both BLM-RAD51-RP-A, together with TRF1 and TRF2, as well as the Mre11-RAD50-NBS1 complex along with TRF1. It remains to be established whether all these proteins are found in the same complex. HR, homologous recombination; NHEJ, nonhomologous end-joining, although the NHEJ factors depicted in the cartoon have also been implicated in HR (Bischof et al., 2001) . These and other observations led the authors to the idea that BLM may be involved in recombinational repair occurring in G2 after DNA damage and that PML may be important for organizing BLM and RAD51 at sites of repair (Bischof et al., 2001) .
As these studies on BLM and PML were proceeding, another interesting connection came to light between PML and ALT. ALT, the acronym for alternative lengthening of telomeres, is an ill-defined process by which some immortalized human cells and cancer cells maintain their telomeres in a telomerase-independent manner (Bryan et al., 1995) . In ALT cell lines, a novel kind of NB has been described in which PML colocalizes with telomeric DNA, the telomere-binding proteins TRF1 and TRF2 as well as proteins involved in DNA recombination and repair such as RP-A, RAD51 and RAD52 (Figure 4c ; Yeager et al., 1999) . These structures were named APB, for ALT-associated PML bodies (Yeager et al., 1999) or AA-PBs, for ALTassociated PML bodies, and are enriched in the G2/ M phase of the cell cycle (Grobelny et al., 2001) . Although the molecular mechanisms underlying telomere maintenance in the absence of telomerase activity in mammalian cells are still not fully elucidated, in yeast this process is known to depend on RAD52-mediated recombination (Lundblad and Blackburn, 1993; Lendvay et al., 1996) . More recent studies on immortalized human cells confirmed the long-lasting belief that ALT involves homologous recombination of telomeric sequences in mammalian cells also (Dunham et al., 2000) . It is therefore not unreasonable to hypothesize that the association of PML with ALT might reflect a more general involvement of PML in homologous recombination processes. In this respect, it is noteworthy that BLM was also found concentrated at telomeres in SV-40-transformed human fibroblasts (Yankiwski et al., 2000) and that this association, as suggested by the authors, could occur in the AA-PBs.
In both yeast and mammals, the RAD50-Mre11-NBS1 complex has also been recently implicated in the maintenance of telomere length in the absence of telomerase (Le et al., 1999; Wu et al., 2000) . The RAD50-Mre11-NBS1 complex stands at the heart of a complex network of DNA damage responses to DNA double strand breaks (DSBs), including homologous and nonhomologous recombination repair (nonhomologous end-joining (NHEJ)), and is also important for checkpoint activation after DNA damage as well as telomere maintenance (Haber, 1998) . Recently, NBS1 and Mre11 have been found to colocalize with TRF1 in AA-PBs, especially during the G2 phase of the cell cycle . However, it is not clear from these studies whether Mre11 and NBS1 colocalize with RP-A, RAD51 and RAD52 in ALT cell lines, along with PML and TRF1 and whether the Mre11 complex directly cooperates with the homologous recombination machinery in mediating telomere lengthening (Figure 4c) .
Interestingly, NBS1 and Mre11 were shown to colocalize partially with PML also in primary human fibroblasts with normal telomeres and not subjected to DNA damage (Figure 4a ; Lombard and Guarente, 2000; Mirzoeva and Petrini, 2001 ). Mammalian cells respond to g-irradiation induced DSBs primarily by activating a NHEJ repair process, particularly during the G1 and early S phases of the cell cycle (Karanjawala et al., 1999) . Immediately after irradiation, the RAD50-Mre11-NBS1 complex localizes to nuclear dots named IR-induced foci that have been proven to be sites of DNA damage and DNA repair, leading to the speculation that RAD50-Mre11-NBS1 might be a sensor of DNA damage (Haber, 1998) . In contrast to recombinational repair proteins, however, Mre11 and NBS1 colocalization with PML decreased when the cells were exposed to 10 Gy of g-irradiation (Figure 4b ; Lombard and Guarente, 2000; Mirzoeva and Petrini, 2001) . At later time points after DNA damage, when the authors suggest that DNA repair has already occurred, Mre11 was found to reassociate to PML (Figure 4b ; Mirzoeva and Petrini, 2001 ). In a subsequent study, PML, Mre11 and p53 localization during DNA repair was analysed in normal human fibroblasts subjected to g-irradiation. In agreement with the previous studies, PML and Mre11 were found to colocalize in undamaged cells, but the colocalization was lost at early time points after DNA damage, when the bulk of DNA repair was found to occur (Carbone et al., 2002) . At later time points, however, PML and Mre11 colocalization resumed and p53 was also found to colocalize with the two proteins (Carbone et al., 2002) . The PML-Mre11 and PML-BLM-RAD51-RP-A foci found at late time points after g-irradiation by different investigators are very likely distinct structures, as Mre11 foci have been shown not to colocalize with RAD51 foci in cells with DSB (Maser et al., 1997) . Moreover, it remains to be established whether PML can dynamically shuttle from one complex to the other, in a time-dependent or cell cycle-dependent manner, or whether it could rather provide a fixed platform associated in some way to DNA to which other components dynamically bind.
Taken together, these results strongly suggest that PML plays a functional role in recombination foci epitomized by the PML/BLM-NB and the AA-PB associated to ALT telomeres. With respect to PML protein complexes found at late time points upon girradiation-induced DSBs, it will be interesting to establish whether these are also sites of recombination repair or are rather involved in checkpoint signaling.
Sumoylation and desumoylation: a PML-NB dynamics for transcriptional regulation and DNA repair in response to apoptotic stimuli?
The PML-NB is a macromolecular structure of doughnut shape (approximately 0.2-1.0 mm in size) as revealed by electron microscopy analysis. More than 50 proteins are found to colocalize with PML in the NB either transiently or constitutively (Jensen et al., 2001 ). Very few NB components physically interact with PML (e.g. p53, pRb, DAXX, CPB; Jensen et al., 2001 and references therein). Although it does not display features of a structural protein, PML is surprisingly essential for the proper formation of the PML-NB. In Pml À/À primary cells, each bona fide NB component no longer accumulates in the PML-NB and acquires an aberrant nuclear localization pattern (Zhong et al., 2000b) . These observations provide a direct explanation for the reason why PML-RARa causes the delocalization of PML and of all PML-NB components even if many of these proteins do not physically interact with the fusion protein. The essential role of PML in the control of NB biogenesis was unforeseen and suggested that PML may modulate diverse and even opposing functions. By contrast, as we have discussed in this review, PML harmonically coordinates, at least in part from the NB, critical functions such as induction of apoptosis under various circumstances.
PML add-back experiments in Pml À/À cells restore PML-NB formation as well as the normal localization pattern of NB components (Zhong et al., 2000b) . By contrast, a mutant protein in which the three PML sumoylatable lysines have been mutagenized displays an aberrant patchy nuclear localization pattern and is unable to rescue NB formation (Zhong et al., 2000b; Lallemand-Breitenbach et al., 2001) . Thus, PML modification by the ubiquitin-like protein SUMO1 is an essential prerequisite for proper NB formation (Zhong et al., 2000a) . This observation allowed proposing a working model by which PML has to be at first sumoylated to be able to recruit other NB components in a mature and properly formed PML-NB (Zhong et al., 2000b) . Also in agreement with this model, time-lapse imaging after photobleaching reveals that NB components including PML are dynamically recruited in the PML-NB (Wiesmeijer et al., 2002) . The picture is further complicated by the fact that sumoylation is a reversible process. The identification of enzymes that can remove the SUMO moiety from its substrates such as ULP1 and SENP1, in fact renders sumoylation-dependent processes dynamic and possibly subject to tight regulation (Zhong et al., 2000b and references therein) . In this respect, PML desumoylation could induce the release and mobilization of PML and NB components from the PML-NB for transcriptional regulation and/or checkpoint/DNA repair in response to apoptotic stimuli. Indeed, a PML desumoylase, SUMO protease 1 (SUPR-1), has been recently identified and as anticipated, its forced overexpression induces a mobilization of PML and NB components (e.g. CBP) from the NB (Best et al., 2002) . PML sumoylation and desumoylation may therefore regulate the function of multiple NB proteins by regulating their in-and out-flow from the NB upon apoptotic stimuli. In the previous paragraph, we have discussed how this could relate to checkpoint and DNA repair responses. On the other hand, mobilization of PML and NB components could be essential to the ability of PML to regulate transcription for the induction of programmed cell death. For example, while p53 is recruited in the PML-NB upon g-irradiation for acetylation, transcriptional activation and possibly stabilization, it is possible that, once activated, p53 is released from the PML-NB in a SUPR-1-PML-desumoylation-dependent manner for DNA-binding and transcription regulation (Figure 2 ). This would also explain why nascent mRNAs and active transcription are not detected in the PML-NBs, but rather in their vicinity (Grande et al., 1996) . Conversely, while the fraction of DAXX in the PML-NB could be transcriptionally inactive although preloaded with corepressors and histone deacetylases (e.g. HDAC1; Zhong et al., 2000b) , dynamic phosphorylation-dependent (e.g. HIPK1-dependent; Ecsedy et al., 2003) release of a DAXX transcriptional repressive complex from the PML-NB could lead to transcriptional repression and apoptosis (Li et al., 2000) . Alternatively, a PML/DAXX complex released from the NB could have distinct transcriptional properties leading to transactivation of proapoptotic genes (Figure 3b) . This dual transcription function may be exerted in a tissue/time-specific manner during embryogenesis and adult life.
Implication for therapy and cancer pathogenesis
The essential role of PML in a number of apoptotic pathways has straightforward implications for cancer/ leukemia pathogenesis and therapy at multiple levels. First of all, PML functional inactivation in APL or other tumors could lend a marked survival advantage to the premalignant/neoplastic cell. This has been well documented in vivo in APL transgenic models and in compound transgenic/KO mutants expressing the PMLRARa fusion protein and lacking one or two copies of the Pml gene (Rego et al., 2001) . The progressive inactivation of Pml function indeed drastically accelerated leukemia onset/incidence and rendered the leukemic cells, as well as myeloid precursors prior to leukemia onset, resistant to apoptotic stimuli (Rego et al., 2001) . Resistance to apoptosis could accelerate leukemogenesis by favoring the expansion of the leukemic blasts or of preleukemic myeloid cells, in turn also favoring the accumulation of additional genetic events (see below). In solid tumors, PML inactivation may reduce anoikis in turn favoring metastatization. In agreement with this hypothesis, PML is lost or reduced in solid tumors of several histological origins and is found to be more frequently lost in late-stage or mestastatic cancers (Gurrieri et al., submittedAQ) .
PML inactivation could also favor leukemia/tumor pathogenesis at a different level: by favoring the accumulation of additional genetic events in a model of multistep tumorigenesis due to genomic instability or through a reduced clearance of DNA-damaged cells via apoptosis. In APL, this notion is supported by the long leukemia latency observed in APL transgenic models and the identification of recurrent karyological abnormalities in the leukemic cells similar to those found in human APL (Zimonjic et al., 2000; Changou et al., 2001; Le Beau et al., 2003) . In this context, PML inactivation by PML-RARa, or PML reduction to heterozygosity due to the fact that one PML allele is involved in the chromosomal translocation, could facilitate the accumulation of additional genetic events. PML inactivation could contribute at two levels not necessarily mutually exclusive: (i) by favoring genomic instability and/or (ii) by rendering cells less prone to die in response to DNA damage/genomic instability. This could be of extreme pathogenetic relevance in human APL, if an initiating event such as a t(15;17) chromosomal translocation occurs in an early myeloid progenitor with little phenotypic consequence, but is followed by the accumulation of additional genetic lesions toward full-blown leukemogenesis. PML functional loss could similarly accelerate multistep tumorigenesis in other malignancies by favoring the accumulation of additional genetic lesions selected by the neoplastic phenotype.
Finally, PML inactivation could render cancer cells resistant to the proapoptotic activity of physical or chemical agents such as ionizing radiation and chemotherapeutic drugs. Selective pressure for PML loss could be therefore imposed on the tumor throughout treatment. In this respect, it is worth mentioning that Pml null cells are resistant to the proapoptotic activity of adryamicin/doxorubicin (Bernardi et al., unpublished observation), a radiomimetic agent, which is currently utilized as a front-line drug in the treatment of APL and other neoplastic disorders.
Conclusions
Analysis of Pml null cells and mice has unequivocally linked the function of PML and the PML-NB to control of programmed cell dead at multiple levels. Functional inactivation or loss of PML in cancer may therefore result in the impairment of a number of apoptotic programs, resulting in a survival advantage to the cancer cell or its unresponsiveness to physical or chemical agents such as ionizing radiation and/or chemotherapeutic agents. PML and the PML-NB can certainly modulate transcriptional proapoptotic pathways, in turn triggering apoptosis or reinforcing proapoptoptic programs. A possible role of PML in the control of genomic stability is also emerging. Although the isoforms of PML so far analysed in greater detail do not appear to possess the ability to bind DNA directly, PML could ensure proper DNA repair and checkpoint enforcement through coordinated interactions and compartmentalization of specialized protein complexes. According to these models, PML would not possess intrinsic enzymatic activities, but rather ensure that relevant enzymatic activities are deployed in a timely and coordinated manner according to dynamic topological constraints in response to apoptotic stimuli (e.g CBP/p300-dependent acetylation of p53 in the PML-NB). Through these mechanisms, PML and the PML-NB could coordinate yet unknown transcriptional proapoptotic programs in response to diverse stimuli/ cellular stresses. In addition, many of the multiple isoforms of PML that are coexpressed in the cell have been poorly characterized. Furthermore, some of these isoforms display a predominantly cytoplasmic localization, where many apoptotic programs are triggered and initially executed. Therefore, it cannot be ruled out that PML might also modulate apoptotic programs or even directly trigger apoptosis through unrecognized biochemical mechanisms, which do not depend on the PML-NB and the nucleus. A more fundamental question is when, during evolution, PML and the PML-NB have been selected to serve such a complex role in the coordination of the cellular response to stress and DNA damage. These remain key questions for PML research to be addressed in the years to come.
